Valion Bio, Inc. Common Stock VBIO
$3.07
-14.01%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | FORM 8-K | 2026-09-01 | View → |
| 8-K | CURRENT REPORT | 2026-08-27 | View → |
| 8-K | CURRENT REPORT | 2026-08-17 | View → |
| 10-Q | FORM 10-Q | 2026-08-14 | View → |
| 8-K | CURRENT REPORT | 2026-08-06 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2026-07-17 | View → |
| S-1 | DRAFT REGISTRATION STATEMENT | 2026-07-17 | View → |
| 8-K | CURRENT REPORT | 2026-07-14 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 8-K | CURRENT REPORT | 2026-06-18 | View → |
| 8-K | CURRENT REPORT | 2026-06-03 | View → |
| 4 | Insider transaction | 2026-05-20 | View → |
| 10-Q | FORM 10-Q | 2026-05-14 | View → |
| 8-K | FORM 8-K | 2026-05-14 | View → |
| 4 | Insider transaction | 2026-05-04 | View → |
| 8-K | FORM 8-K | 2026-05-04 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2026-04-30 | View → |
| 8-K | CURRENT REPORT | 2026-04-23 | View → |
| 4 | Insider transaction | 2026-04-20 | View → |
| S-1 | FORM S-1 | 2026-04-13 | View → |
| 4 | Insider transaction | 2026-04-02 | View → |
| 10-K | FORM 10-K | 2026-03-30 | View → |
| 8-K | FORM 8-K | 2026-03-25 | View → |
| 8-K | FORM 8-K | 2026-03-20 | View → |
| 4 | Insider transaction | 2026-03-19 | View → |
| 8-K | CURRENT REPORT | 2026-03-13 | View → |
| 8-K | FORM 8-K | 2026-03-11 | View → |
| 8-K | CURRENT REPORT | 2026-03-04 | View → |
| 4 | Insider transaction | 2026-02-20 | View → |
| 8-K | FORM 8-K | 2026-02-09 | View → |
| 8-K | CURRENT REPORT | 2026-01-20 | View → |
| DEF 14A | DEF 14A | 2026-01-09 | View → |
| S-3 | FORM S-3 REGISTRATION STATEMENT | 2025-12-29 | View → |
| S-3 | FORM S-3 REGISTRATION STATEMENT | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-22 | View → |
| 4 | Insider transaction | 2025-12-22 | View → |
| 8-K | CURRENT REPORT | 2025-12-11 | View → |
| 8-K | FORM 8-K | 2025-11-18 | View → |
| 10-Q | FORM 10-Q | 2025-11-14 | View → |
| 8-K | FORM 8-K | 2025-11-14 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $3.07
- Market Cap
- $3.17 million
- 52-Week Range
- $2.79 – $32.50
- Average Volume
- 769K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.